S&P 500
5,981.86
+0.2%
+$11.49
DJI
42,557.47
+0.1%
+$37.83
NASDAQ
19,445.53
+0.2%
+$46.58
Bitcoin
105,328.00
-0.9%
-986.60
AAPL
$203.29
+0.0%
+$0.02
AMZN
$206.87
+0.6%
+$1.16
GOOG
$168.27
+0.3%
+$0.56
META
$683.13
+2.4%
+$16.28
MSFT
$464.39
+0.3%
+$1.42
NVDA
$140.61
-0.4%
-$0.61
TSLA
$332.77
-3.3%
-$11.50
Cartesian Therapeutics (NASDAQ: RNAC)
$9.50
(-4.0%)
-$0.40
Price as of June 4, 2025, 12:46 p.m. ET
Cartesian Therapeutics Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Cartesian Therapeutics Company Info
Cartesian Therapeutics, Inc. operates as a clinical-stage biotechnology company. It provides RNA cell therapies for the treatment of autoimmune diseases. The company is headquartered in Gaithersburg, MD.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.